Inference of dynamic biological networks based on responses to drug perturbations

被引:5
作者
Berlow, Noah [1 ]
Davis, Lara [2 ]
Keller, Charles [2 ]
Pal, Ranadip [1 ]
机构
[1] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA
[2] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA
来源
EURASIP JOURNAL ON BIOINFORMATICS AND SYSTEMS BIOLOGY | 2014年 / 01期
基金
美国国家科学基金会;
关键词
Drug perturbation experiments; Network inference; Pathway design;
D O I
10.1186/s13637-014-0014-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Drugs that target specific proteins are a major paradigm in cancer research. In this article, we extend a modeling framework for drug sensitivity prediction and combination therapy design based on drug perturbation experiments. The recently proposed target inhibition map approach can infer stationary pathway models from drug perturbation experiments, but the method is limited to a steady-state snapshot of the underlying dynamical model. We consider the inverse problem of possible dynamic models that can generate the static target inhibition map model. From a deterministic viewpoint, we analyze the inference of Boolean networks that can generate the observed binarized sensitivities under different target inhibition scenarios. From a stochastic perspective, we investigate the generation of Markov chain models that satisfy the observed target inhibition sensitivities.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 26 条
  • [1] The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
    Barretina, Jordi
    Caponigro, Giordano
    Stransky, Nicolas
    Venkatesan, Kavitha
    Margolin, Adam A.
    Kim, Sungjoon
    Wilson, Christopher J.
    Lehar, Joseph
    Kryukov, Gregory V.
    Sonkin, Dmitriy
    Reddy, Anupama
    Liu, Manway
    Murray, Lauren
    Berger, Michael F.
    Monahan, John E.
    Morais, Paula
    Meltzer, Jodi
    Korejwa, Adam
    Jane-Valbuena, Judit
    Mapa, Felipa A.
    Thibault, Joseph
    Bric-Furlong, Eva
    Raman, Pichai
    Shipway, Aaron
    Engels, Ingo H.
    Cheng, Jill
    Yu, Guoying K.
    Yu, Jianjun
    Aspesi, Peter, Jr.
    de Silva, Melanie
    Jagtap, Kalpana
    Jones, Michael D.
    Wang, Li
    Hatton, Charles
    Palescandolo, Emanuele
    Gupta, Supriya
    Mahan, Scott
    Sougnez, Carrie
    Onofrio, Robert C.
    Liefeld, Ted
    MacConaill, Laura
    Winckler, Wendy
    Reich, Michael
    Li, Nanxin
    Mesirov, Jill P.
    Gabriel, Stacey B.
    Getz, Gad
    Ardlie, Kristin
    Chan, Vivien
    Myer, Vic E.
    [J]. NATURE, 2012, 483 (7391) : 603 - 607
  • [2] A new approach for prediction of tumor sensitivity to targeted drugs based on functional data
    Berlow, Noah
    Davis, Lara E.
    Cantor, Emma L.
    Seguin, Bernard
    Keller, Charles
    Pal, Ranadip
    [J]. BMC BIOINFORMATICS, 2013, 14
  • [3] Berlow N, 2012, 2012 IEEE STATISTICAL SIGNAL PROCESSING WORKSHOP (SSP), P552, DOI 10.1109/SSP.2012.6319757
  • [4] Modeling and simulation of genetic regulatory systems: A literature review
    De Jong, H
    [J]. JOURNAL OF COMPUTATIONAL BIOLOGY, 2002, 9 (01) : 67 - 103
  • [5] Molecularly targeted Therapy: Have the floodgates opened?
    Druker, BJ
    [J]. ONCOLOGIST, 2004, 9 (04) : 357 - 360
  • [6] Systematic identification of genomic markers of drug sensitivity in cancer cells
    Garnett, Mathew J.
    Edelman, Elena J.
    Heidorn, Sonja J.
    Greenman, Chris D.
    Dastur, Anahita
    Lau, King Wai
    Greninger, Patricia
    Thompson, I. Richard
    Luo, Xi
    Soares, Jorge
    Liu, Qingsong
    Iorio, Francesco
    Surdez, Didier
    Chen, Li
    Milano, Randy J.
    Bignell, Graham R.
    Tam, Ah T.
    Davies, Helen
    Stevenson, Jesse A.
    Barthorpe, Syd
    Lutz, Stephen R.
    Kogera, Fiona
    Lawrence, Karl
    McLaren-Douglas, Anne
    Mitropoulos, Xeni
    Mironenko, Tatiana
    Thi, Helen
    Richardson, Laura
    Zhou, Wenjun
    Jewitt, Frances
    Zhang, Tinghu
    O'Brien, Patrick
    Boisvert, Jessica L.
    Price, Stacey
    Hur, Wooyoung
    Yang, Wanjuan
    Deng, Xianming
    Butler, Adam
    Choi, Hwan Geun
    Chang, JaeWon
    Baselga, Jose
    Stamenkovic, Ivan
    Engelman, Jeffrey A.
    Sharma, Sreenath V.
    Delattre, Olivier
    Saez-Rodriguez, Julio
    Gray, Nathanael S.
    Settleman, Jeffrey
    Futreal, P. Andrew
    Haber, Daniel A.
    [J]. NATURE, 2012, 483 (7391) : 570 - U87
  • [7] Targeting targeted therapy
    Green, MR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2191 - 2193
  • [8] Can we rationally design promiscuous drugs?
    Hopkins, AL
    Mason, JS
    Overington, JP
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2006, 16 (01) : 127 - 136
  • [9] Kauffman S.A., 1993, ORIGINS ORDER
  • [10] Features of selective kinase inhibitors
    Knight, ZA
    Shokat, KM
    [J]. CHEMISTRY & BIOLOGY, 2005, 12 (06): : 621 - 637